These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3263891

  • 1. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
    Boiskin I, Epstein S, Ismail F, Fallon MD, Levy W.
    Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
    [Abstract] [Full Text] [Related]

  • 2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 3. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S.
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [Abstract] [Full Text] [Related]

  • 5. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S.
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [Abstract] [Full Text] [Related]

  • 6. TEI-3313, a novel prostaglandin A1 derivative, prevents bone loss and enhances bone formation in immobilized male rats.
    Ohta T, Azuma Y, Kanatani H, Kiyoki M, Koshihara Y.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):450-5. PubMed ID: 7562584
    [Abstract] [Full Text] [Related]

  • 7. 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry.
    Jowell PS, Epstein S, Fallon MD, Reinhardt TA, Ismail F.
    Endocrinology; 1987 Feb; 120(2):531-6. PubMed ID: 3492365
    [Abstract] [Full Text] [Related]

  • 8. Effect of low doses of stable strontium on bone metabolism in rats.
    Marie PJ, Garba MT, Hott M, Miravet L.
    Miner Electrolyte Metab; 1985 Feb; 11(1):5-13. PubMed ID: 3974537
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA, Jee WS, Joffe II, Stein B, Takizawa M, Jacobs TW, Setterberg R, Lin BY, Tang LY, Ke HZ.
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S.
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C, Schlosberg M, Epstein S, Ismail F, Fallon M, Thomas S.
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat.
    Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Paynton BV, Jee WS, Hendy GN, Epstein S.
    J Bone Miner Res; 1995 Oct; 10(10):1556-65. PubMed ID: 8686513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    Endocrinology; 1988 Nov; 123(5):2571-7. PubMed ID: 3262506
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
    Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S.
    Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 Jul; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

  • 20. Indomethacin inhibits bone formation in inductive allografts but not in autografts: studies in rat.
    Persson PE, Sisask G, Nilsson O.
    Acta Orthop; 2005 Aug; 76(4):465-9. PubMed ID: 16195059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.